Literature DB >> 18250465

Tristetraprolin regulates CXCL1 (KC) mRNA stability.

Shyamasree Datta1, Roopa Biswas, Michael Novotny, Paul G Pavicic, Tomasz Herjan, Palash Mandal, Thomas A Hamilton.   

Abstract

mRNAs encoding proinflammatory chemokines are regulated posttranscriptionally via adenine-uridine-rich sequences (AREs) located in the 3' untranslated region of the message, which are recognized by sequence-specific RNA-binding proteins. One ARE binding protein, tristetraprolin (TTP), has been implicated in regulating the stability of several ARE-containing mRNAs, including those encoding TNF-alpha and GM-CSF. In the present report we examined the role of TTP in regulating the decay of the mouse chemokine KC (CXCL1) mRNA. Using tetR-regulated control of transcription in TTP-deficient HEK293 cells, KC mRNA half-life was markedly decreased in the presence of TTP. Deletion and site-specific mutagenesis were used to identify multiple AUUUA sequence determinants responsible for TTP sensitivity. Although a number of studies suggest that the destabilizing activity of TTP is subject to modulation in response to ligands of Toll/IL-1 family receptors, decay mediated by TTP in 293 cells was not sensitive to stimulation with IL-1alpha. Using primary macrophages from wild-type and TTP-deficient mice, KC mRNA instability was found to be highly dependent on TTP. Furthermore, LPS-mediated stabilization of KC mRNA is blocked by inhibition of the p38 MAPK in macrophages from wild-type but not TTP-deficient mice. These findings demonstrate that TTP is the predominant regulator of KC mRNA decay in mononuclear phagocytes acting via multiple 3'-untranslated region-localized AREs. Nevertheless, KC mRNA remains highly unstable in cells that do not express TTP, suggesting that additional determinants of instability and stimulus sensitivity may operate in cell populations where TTP is not expressed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250465     DOI: 10.4049/jimmunol.180.4.2545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.

Authors:  Xuesong Qian; Huan Ning; Jidong Zhang; Daniel F Hoft; Deborah J Stumpo; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 2.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

3.  Molecular identification of the gene encoding porcine tristetraprolin (TTP).

Authors:  Zheng-Bing Guan; Yan Shui; Jian Lu
Journal:  Mol Cell Biochem       Date:  2010-08-19       Impact factor: 3.396

Review 4.  Inflammation: cytokines and RNA-based regulation.

Authors:  Deborah J Stumpo; Wi S Lai; Perry J Blackshear
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

5.  Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.

Authors:  Sandra L Clement; Claudia Scheckel; Georg Stoecklin; Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

6.  Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation.

Authors:  Ling Gu; Huan Ning; Xuesong Qian; Qi Huang; Rong Hou; Rajaa Almourani; Mingui Fu; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

7.  IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation.

Authors:  Craig M Brackett; Jason B Muhitch; Sharon S Evans; Sandra O Gollnick
Journal:  J Immunol       Date:  2013-09-11       Impact factor: 5.422

8.  Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

Authors:  Dongxu Sun; Michael Novotny; Katarzyna Bulek; Caini Liu; Xiaoxia Li; Thomas Hamilton
Journal:  Nat Immunol       Date:  2011-08-07       Impact factor: 25.606

Review 9.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

Review 10.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.